Objective -To explain the reasons for geographical variation in the use of coronary revascularisation in the United Kingdom. Design -This was a cross sectional ecological study. Setting -NHS and independent hospitals performing coronary revascularisation for the Wide variation has been reported in the utilisation rates of coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) between regions of the United Kingdom89 within North America,'0-"2 and between countries in Europe." Only four studies, however, have attempted to explain why such differences exist, and these limited their enquiries to a restricted number of possible determinants. The only factors to have been shown to be associated with the utilisation rate have been the availability of facilities, in particular catheterisation laboratories,'3-'5 and the distance patients live from these facilities. 6 No association has been found with the rate of use of alternative therapies and the level of coronary heart disease morbidity in the population. '3 151718 In an attempt to understand the reasons for variation in revascularisation rates in the UK, some preliminary analyses were undertaken on 1991-92 data and reported in a Clinical Standards Advisory Group report on the availability of and access to CABG and PTCA.'9 This paper describes more detailed analyses of the variations that occurred during 1992-93.
Abstract
Objective -To explain the reasons for geographical variation in the use of coronary revascularisation in the United Kingdom. Design -This was a cross sectional ecological study. Setting -NHS and independent hospitals performing coronary revascularisation for the Results -Considerable systematic variations in district rates of CABG and PTCA existed. These variations mostly arose from differences in supply factors. Higher rate districts were characterised by being close to a regional revascularisation centre and having a local cardiologist. Demand factors such as the level of need in the population (measured by coronary heart disease mortality) and the lack of use of alternative treatments not only failed to explain the observed variation but were inversely associated with the rate of intervention -an example ofthe inverse care law. The finding that the residents of more socially deprived districts experienced higher intervention rates was probably subject to confounding due to their close proximity to specialist centres.
Conclusions -If greater geographical equity of use for the same level of need is to be achieved, attention must be paid to the supply factors that determine levels of utilisation. As America,'0-"2 and between countries in Europe." Only four studies, however, have attempted to explain why such differences exist, and these limited their enquiries to a restricted number of possible determinants. The only factors to have been shown to be associated with the utilisation rate have been the availability of facilities, in particular catheterisation laboratories,'3-'5 and the distance patients live from these facilities. 6 No association has been found with the rate of use of alternative therapies and the level of coronary heart disease morbidity in the population. '3 151718 In an attempt to understand the reasons for variation in revascularisation rates in the UK, some preliminary analyses were undertaken on 1991-92 data and reported in a Clinical Standards Advisory Group report on the availability of and access to CABG and PTCA. ' Standardised mortality rates for coronary heart disease 1990-91 Table 2 Relationship between district revascularisation rates and proxy measures of morbidity (correlation coefficients plus 95% confidence intervals) In practice, the opposite occurred. This study has taken a cross sectional look at variation between districts. It is perhaps to be expected that large differences would be found in the rates of PTCA given its recent introduction as a new technology and the provision of CABG is still increasing as additional centres are established and existing ones expand. Given these continued developments, a reduction in the extent of variation between districts might be expected to occur over the coming years as the availability of services increases (though differences in clinical judgment would continue to ensure some variation persisted). However, as the purchasing of these procedures is decentralised from regions to consortia of districts to individual districts and finally to general practitioners it is quite likely that variations in use will increase rather than decrease. 
